Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 5Lymphoid 4Plasma cell 2Classical hematology 2Genitourinary 1

Conditions

Carcinoma, Renal Cell 3Kidney Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 5Antilymphocyte Serum 5fludarabine phosphate 4Flow Cytometry 4Tacrolimus 3Mycophenolic Acid 3Filgrastim 3Azacitidine 3Alemtuzumab 3thymoglobulin 2ruxolitinib 2abiraterone 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Microarray Analysis 2Methylprednisolone 2Methotrexate 2Immunologic Techniques 2Cyclosporine 2Busulfan 2Biopsy 2venetoclax 1trametinib 1sargramostim 1rucaparib 1regorafenib 1ponatinib 1pertuzumab 1pembrolizumab 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myelodysplastic Syndromes × Pentostatin × Genitourinary × Clear all
NCT00698685 2017-03-31

Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

University of Arizona

Phase 2 Terminated
14 enrolled 7 charts
GenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cell

Carcinoma, Renal Cell, Hodgkin Disease, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡